Ponce De Leon Pharmaceuticals

Company profile

Ponce De Leon Pharmaceuticals company profile

Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. This formulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.